SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-223884
Filing Date
2012-05-10
Accepted
2012-05-10 09:01:08
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d326013d10q.htm 10-Q 537215
2 SECTION 302 CEO CERTIFICATION d326013dex311.htm EX-31.1 6856
3 SECTION 302 CFO CERTIFICATION d326013dex312.htm EX-31.2 6812
4 SECTION 906 CEO CERTIFICATION d326013dex321.htm EX-32.1 4310
5 SECTION 906 CFO CERTIFICATION d326013dex322.htm EX-32.2 4304
  Complete submission text file 0001193125-12-223884.txt   1964239

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT avii-20120331.xml EX-101.INS 218339
7 XBRL TAXONOMY EXTENSION SCHEMA avii-20120331.xsd EX-101.SCH 14089
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE avii-20120331_cal.xml EX-101.CAL 33367
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE avii-20120331_lab.xml EX-101.LAB 120633
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE avii-20120331_pre.xml EX-101.PRE 76571
Mailing Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021
Business Address 3450 MONTE VILLA PARKWAY SUITE 101 BOTHELL WA 98021 425-354-5038
AVI BIOPHARMA INC (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: OR | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14895 | Film No.: 12827910
SIC: 2834 Pharmaceutical Preparations